| 注册
首页|期刊导航|实用医学杂志|PAR-2、VEGF 和CD34在胃癌组织中的表达及其临床意义

PAR-2、VEGF 和CD34在胃癌组织中的表达及其临床意义

张成 高广荣 李达 吕晨光 蒋会勇 李瑾 张雪峰

实用医学杂志2013,Vol.29Issue(11):1773-1776,4.
实用医学杂志2013,Vol.29Issue(11):1773-1776,4.DOI:10.3969/j.issn.1006-5725.2013.11.021

PAR-2、VEGF 和CD34在胃癌组织中的表达及其临床意义

Expression and significance of protease-activated receptor-2, VEGF and CD34 in gastric cancer tissue

张成 1高广荣 1李达 1吕晨光 1蒋会勇 1李瑾 1张雪峰1

作者信息

  • 1. 110840,沈阳军区总医院普通外科
  • 折叠

摘要

Abstract

Objective To investigate the expression and clinicopathological significance of PAR-2, VEGF and CD34 in gastric carcinoma tissues. Methods PAR-2, VEGF and CD34 were detected by immunohistochemistry, and the correlation of PAR-2 expression with VEGF and CD34 expressions and clinical pathologic factors was analyzed. Results Immunohistochemistry results showed that the positive expressions of PAR-2 , CD34 and VEGF in gastric carcinoma tissues were 52.5%, 63.8% and 65.0%. PAR-2 expression in the cell membrane and cytoplasm of tumor cells, whereas VEGF mainly in the cytoplasm. Linear correlation analysis showed significant inverse relationship between expression of PAR-2 and clinical stage, depth of infiltration and distant metastasis, and positive correlation between expression of PAR-2 and VEGF, CD34. Conclusion The overexpression of PAR-2 is related with the neovascularization in gastric carcinoma tissues.

关键词

胃肿瘤/蛋白酶激活受体-2/血管内皮细胞生长因子/CD34

Key words

Stomach neoplasms/ Protease-activated receptor-2/ VEGF/ CD34

引用本文复制引用

张成,高广荣,李达,吕晨光,蒋会勇,李瑾,张雪峰..PAR-2、VEGF 和CD34在胃癌组织中的表达及其临床意义[J].实用医学杂志,2013,29(11):1773-1776,4.

基金项目

中国博士后科学基金资助项目(编号:20090451564) (编号:20090451564)

实用医学杂志

OA北大核心CSTPCD

1006-5725

访问量0
|
下载量0
段落导航相关论文